Head-to-Head on Each Axis
Muscle Building Effect
Low-dose HGH (2 IU/day): 3-5 lb lean mass gain in 12-16 weeks, modest body recomp.
Mid-dose HGH (4 IU/day): 5-8 lb lean mass, significant recomp.
High-dose HGH (6+ IU/day): 8-12 lb lean mass, dramatic transformation, significant side effects.
Tesamorelin + ipamorelin: 3-5 lb lean mass, matches low-to-mid-dose HGH with tesamorelin's phase III data backing the body-comp endpoint (Falutz et al., 2010).
CJC-1295 + ipamorelin: 2-3 lb lean mass, matches low-dose HGH.
Winner on pure muscle building: high-dose HGH, by a clear margin.
Winner on cost-per-lb of lean mass: peptides, at every dose level.
Fat Loss
HGH is famous for fat loss, particularly visceral. At 2 IU/day HGH, visceral fat drops ~10-15% over 12-16 weeks. At 4 IU/day, 15-25%.
Tesamorelin + ipamorelin matches this directly — Falutz 2010 phase III trial showed 15-18% visceral fat reduction at 26 weeks on tesamorelin 2 mg/day. CJC+ipa produces about half that effect.
Winner: tie between HGH and tesa+ipa for visceral fat; HGH for subcutaneous fat at higher doses.
Recovery and Sleep
HGH at any dose produces sleep deepening and recovery acceleration — often within 2-3 days.
Peptide stacks (especially paired GHRH+GHRP pre-bed) produce similar sleep deepening, often within 2-3 days.
Winner: effectively tied. Most users can't distinguish the sleep benefit between HGH and peptides at equivalent IGF-1 elevation.
Side Effect Profile
HGH common side effects:
Insulin resistance (often requires metformin)
Carpal tunnel syndrome symptoms
Sleep apnea worsening
Joint pain and swelling
Fluid retention
Cardiac remodeling with long-term use
Peptide stack common side effects:
Injection site irritation
Mild water retention (first 1-2 weeks)
Modest fasting glucose increase (more pronounced on MK-677)
Vivid dreams
Minor hand tingling (GH-related fluid)
Winner: peptides, decisively.
Cost per Cycle
Research chemical HGH: $40-80/day at 2-4 IU = $3,500-9,000 per year at daily dosing.
Tesa+ipa: $150-250 per 10 mg vial (lasts ~5 weeks at 2 mg/day) = $1,500-2,500 per year.
CJC+ipa: $80-120 per 5 mg vial (lasts ~5 weeks) = $800-1,200 per year.
Winner: peptides, at every dose level.
Bloodwork Cadence
HGH users need quarterly fasting glucose and HbA1c at minimum; many add fasting insulin and OGTT.
Peptide users need baseline, week 4, week 12 labs — lighter cadence, easier to interpret.
Winner: peptides.
When HGH Is Actually the Right Choice
Competitive bodybuilders. Top-end physique sports require muscle gains peptides can't match. The cost and side effects are accepted trade-offs.
Users with documented adult GH deficiency. Diagnosed hypopituitarism requires HGH replacement, not GH secretagogues. The pituitary isn't the problem in this population.
Athletes needing predictable response. HGH dosing is linear; peptide response varies by individual. Some users simply don't respond well to GHRH+GHRP (low pituitary reserve, unusual receptor expression) and HGH bypasses that issue.
When Peptides Are the Right Choice
Everyone else. Over 90% of users chasing muscle and recomp with GH-axis pharmacology should start with peptides. The cost, safety, and legal picture all favor peptides unless you have a specific reason HGH is required.
Beginners. Start with CJC-1295 + ipamorelin. If you see good IGF-1 elevation and body-comp response, peptides are your tool. If you don't respond, HGH is available — but most people respond.
Top CJC-1295 + Ipamorelin Vendors
Ranked by price, COA availability, and reputation
Over 40. Age-related GH decline is a pituitary pacing problem, not a pituitary capability problem. GHRH+GHRP directly addresses the cause. HGH at older ages raises insulin-resistance risk disproportionately.
Top Sermorelin Vendors
Cost-constrained users. Peptides are 2-5x cheaper for comparable IGF-1 response.
Body-composition-focused users. Tesamorelin+ipamorelin has the strongest RCT evidence for body-comp outcomes of any GH-axis intervention. Better than off-label HGH data.
Top Tesamorelin + Ipamorelin Vendors
How to Choose
Standard muscle/recomp goal, normal budget → CJC-1295 + ipamorelin.
Body recomposition priority, budget ok → Tesamorelin + ipamorelin.
First GH peptide over 40 → Sermorelin + ipamorelin.
Competitive bodybuilder with contest timeline → HGH 4-6 IU/day (under medical supervision ideal, with peptide adjuncts).
Documented adult GH deficiency → Physician-prescribed HGH replacement.
Have tried peptides and didn't respond → Bloodwork-guided HGH protocol at minimum effective dose.
Related Reading
Best Peptides for Muscle Growth — GH peptide stack ranking
Best Peptides for Muscle Over 40 — age-specific
Beginner Peptide Stack for Muscle — first cycle setup
Peptides vs SARMs vs Steroids — cross-category comparison
Peptide Muscle Timeline — week-by-week expectations
Tesamorelin Results Timeline — single-peptide deep dive
GHRH vs GHRP — within-class comparison
References
1
Bowers CY, et al. GH-releasing peptide acts synergistically with GH-releasing hormone. J Clin Endocrinol Metab. 1990;70(4):975-982.
2108187
2
Falutz J, et al. Effects of tesamorelin in HIV-infected patients with abdominal fat accumulation. J Clin Endocrinol Metab. 2010;95(9):4291-4304.
20101189
3
Adrian S, et al. Tesamorelin decreases muscle fat and increases muscle area in adults with HIV. J Frailty Aging. 2019;8(3):154-159.
31237318
4
Teichman SL, et al. Prolonged stimulation of GH and IGF-I secretion by CJC-1295. J Clin Endocrinol Metab. 2006;91(3):799-805.
16352683
5
Raun K, et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol. 1998;139(5):552-561.
9849822
6
Nass R, et al. Effects of an oral ghrelin mimetic on body composition in healthy older adults. Ann Intern Med. 2008;149(9):601-611.
18981485
7
Stanley TL, et al. Effect of tesamorelin on visceral fat and liver fat in HIV-infected patients. JAMA. 2014;312(4):380-389.
25038357
8
Pandya N, et al. GHRP-6 requires endogenous hypothalamic GHRH for maximal GH stimulation. J Clin Endocrinol Metab. 1998;83(4):1186-1189.
9543138